Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: This study seems to cast a shadow on med combos...

Posted by Terry8 on May 4, 2011, at 12:25:22

In reply to Re: This study seems to cast a shadow on med combos..., posted by Phillipa on May 4, 2011, at 10:55:46

> I feel it's interesting that the funding seems to be both by NIMH and the dug companies. Phillipa

The funding was by NIMH. The drug companies simply provided the drugs. And even if they had also provided funding, it's not like the results being reported benefit the drug companies.

From what I understand, their results only address combos versus monotherapy as a first-line treatment. I wasn't aware that it was even that common to prescribe more than one AD as a first-line treatment. I'll be more intrigued when I see results that address monotherapy versus combos for treatment resistant cases, which is when you see combos being used more often.




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:Terry8 thread:984479